Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Technology
1.2.2. End Use
1.2.3. Regional scope
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Technology outlook
2.2.2. End Use outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Malaria Diagnostics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing demand for diagnostic tools in malaria-endemic countries
3.2.1.2. Development of technologically advanced and efficient diagnostics
3.2.1.3. Market players and private investors to curb the prevalence of malaria
3.2.2. Market restraint analysis
3.2.2.1. Increasing number of countries in the malaria elimination phase
3.2.2.2. Demand for low-cost malaria diagnostic tests
3.3. Malaria Diagnostics Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. Malaria Diagnostics Market: Technology Estimates & Trend Analysis
4.1. Technology Market Share, 2024 & 2033
4.2. Segment Dashboard
4.3. Global Malaria Diagnostics Market by Technology Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2024 to 2033 for the following
4.4.1. Molecular Diagnostic Tests
4.4.1.1. Market estimates and forecasts 2025 to 2033
4.4.1.2. Conventional PCR
4.4.1.2.1. Market estimates and forecasts 2025 to 2033
4.4.1.3. Modernized PCR
4.4.1.3.1. Market estimates and forecasts 2025 to 2033
4.4.2. Microscopy
4.4.2.1. Market estimates and forecasts 2025 to 2033
4.4.3. Rapid Diagnostic Tests (RDT)
Chapter 5. Malaria Diagnostics Market: End Use Estimates & Trend Analysis
5.1. Method Market Share, 2024 & 2033
5.2. Segment Dashboard
5.3. Global Malaria Diagnostics Market by End Use Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2024 to 2033 for the following
5.4.1. Hospitals & Clinics
5.4.1.1. Market estimates and forecasts 2025 to 2033
5.4.2. Diagnostic Centers
5.4.2.1. Market estimates and forecasts 2025 to 2033
5.4.3. Academic and Research Institutes
5.4.3.1. Market estimates and forecasts 2025 to 2033
Chapter 6. Malaria Diagnostics Market: Regional Estimates & Trend Analysis
6.1. Regional Market Share Analysis, 2024 & 2033
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. Market Size, & Forecasts Trend Analysis, 2024 to 2033:
6.5. Africa
6.5.1. Nigeria
6.5.1.1. Key country dynamics
6.5.1.2. Regulatory framework/ reimbursement structure
6.5.1.3. Competitive scenario
6.5.1.4. Nigeria market estimates and forecasts 2025 to 2033
6.5.2. Democratic Republic of the Congo
6.5.2.1. Key country dynamics
6.5.2.2. Regulatory framework/ reimbursement structure
6.5.2.3. Competitive scenario
6.5.2.4. Democratic Republic of the Congo market estimates and forecasts 2025 to 2033
6.5.3. United Republic of Tanzania
6.5.3.1. Key country dynamics
6.5.3.2. Regulatory framework/ reimbursement structure
6.5.3.3. Competitive scenario
6.5.3.4. United Republic of Tanzania market estimates and forecasts 2025 to 2033
6.5.4. Uganda
6.5.4.1. Key country dynamics
6.5.4.2. Regulatory framework/ reimbursement structure
6.5.4.3. Competitive scenario
6.5.4.4. Uganda market estimates and forecasts 2025 to 2033
6.5.5. South Africa
6.5.5.1. Key country dynamics
6.5.5.2. Regulatory framework/ reimbursement structure
6.5.5.3. Competitive scenario
6.5.5.4. South Africa market estimates and forecasts 2025 to 2033
6.5.6. Mozambique
6.5.6.1. Key country dynamics
6.5.6.2. Regulatory framework/ reimbursement structure
6.5.6.3. Competitive scenario
6.5.6.4. Mozambique market estimates and forecasts 2025 to 2033
6.5.7. Angola
6.5.7.1. Key country dynamics
6.5.7.2. Regulatory framework/ reimbursement structure
6.5.7.3. Competitive scenario
6.5.7.4. Angola market estimates and forecasts 2025 to 2033
6.5.8. Ghana
6.5.8.1. Key country dynamics
6.5.8.2. Regulatory framework/ reimbursement structure
6.5.8.3. Competitive scenario
6.5.8.4. Ghana market estimates and forecasts 2025 to 2033
6.5.9. Botswana
6.5.9.1. Key country dynamics
6.5.9.2. Regulatory framework/ reimbursement structure
6.5.9.3. Competitive scenario
6.5.9.4. Botswana market estimates and forecasts 2025 to 2033
6.5.10. Namibia
6.5.10.1. Key country dynamics
6.5.10.2. Regulatory framework/ reimbursement structure
6.5.10.3. Competitive scenario
6.5.10.4. Namibia market estimates and forecasts 2025 to 2033
6.6. South East Asia
6.6.1. India
6.6.1.1. Key country dynamics
6.6.1.2. Regulatory framework/ reimbursement structure
6.6.1.3. Competitive scenario
6.6.1.4. India market estimates and forecasts 2025 to 2033
6.6.2. Myanmar
6.6.2.1. Key country dynamics
6.6.2.2. Regulatory framework/ reimbursement structure
6.6.2.3. Competitive scenario
6.6.2.4. Myanmar market estimates and forecasts 2025 to 2033
6.6.3. Indonesia
6.6.3.1. Key country dynamics
6.6.3.2. Regulatory framework/ reimbursement structure
6.6.3.3. Competitive scenario
6.6.3.4. Indonesia market estimates and forecasts 2025 to 2033
6.7. Eastern Mediterranean
6.7.1. Saudi Arabia
6.7.1.1. Key country dynamics
6.7.1.2. Regulatory framework/ reimbursement structure
6.7.1.3. Competitive scenario
6.7.1.4. Saudi Arabia market estimates and forecasts 2025 to 2033
6.7.2. Pakistan
6.7.2.1. Key country dynamics
6.7.2.2. Regulatory framework/ reimbursement structure
6.7.2.3. Competitive scenario
6.7.2.4. Pakistan market estimates and forecasts 2025 to 2033
6.8. Western Pacific
6.8.1. China
6.8.1.1. Key country dynamics
6.8.1.2. Regulatory framework/ reimbursement structure
6.8.1.3. Competitive scenario
6.8.1.4. China market estimates and forecasts 2025 to 2033
6.8.2. Papua New Guinea
6.8.2.1. Key country dynamics
6.8.2.2. Regulatory framework/ reimbursement structure
6.8.2.3. Competitive scenario
6.8.2.4. Papua New Guinea market estimates and forecasts 2025 to 2033
6.8.3. Cambodia
6.8.3.1. Key country dynamics
6.8.3.2. Regulatory framework/ reimbursement structure
6.8.3.3. Competitive scenario
6.8.3.4. Cambodia market estimates and forecasts 2025 to 2033
6.9. Americas
6.9.1. Venezuela
6.9.1.1. Key country dynamics
6.9.1.2. Regulatory framework/ reimbursement structure
6.9.1.3. Competitive scenario
6.9.1.4. Venezuela market estimates and forecasts 2025 to 2033
6.9.2. Brazil
6.9.2.1. Key country dynamics
6.9.2.2. Regulatory framework/ reimbursement structure
6.9.2.3. Competitive scenario
6.9.2.4. Brazil market estimates and forecasts 2025 to 2033
6.9.3. Colombia
6.9.3.1. Key country dynamics
6.9.3.2. Regulatory framework/ reimbursement structure
6.9.3.3. Competitive scenario
6.9.3.4. Colombia market estimates and forecasts 2025 to 2033
6.10. Europe
6.10.1. UK
6.10.1.1. Key country dynamics
6.10.1.2. Regulatory framework/ reimbursement structure
6.10.1.3. Competitive scenario
6.10.1.4. UK market estimates and forecasts 2025 to 2033
6.10.2. Germany
6.10.2.1. Key country dynamics
6.10.2.2. Regulatory framework/ reimbursement structure
6.10.2.3. Competitive scenario
6.10.2.4. Germany market estimates and forecasts 2025 to 2033
6.10.3. France
6.10.3.1. Key country dynamics
6.10.3.2. Regulatory framework/ reimbursement structure
6.10.3.3. Competitive scenario
6.10.3.4. France market estimates and forecasts 2025 to 2033
6.10.4. Turkey
6.10.4.1. Key country dynamics
6.10.4.2. Regulatory framework/ reimbursement structure
6.10.4.3. Competitive scenario
6.10.4.4. Turkey market estimates and forecasts 2025 to 2033
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company market share analysis, 2023
7.3.4. Access Bio, Inc.
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Product benchmarking
7.3.4.4. Strategic initiatives
7.3.5. Abbott Laboratories
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Product benchmarking
7.3.5.4. Strategic initiatives
7.3.6. Premier Medical Corporation Pvt. Ltd.
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Product benchmarking
7.3.6.4. Strategic initiatives
7.3.7. Sysmex Partec GmbH
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Product benchmarking
7.3.7.4. Strategic initiatives
7.3.8. bioMérieux
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Product benchmarking
7.3.8.4. Strategic initiatives
7.3.9. Beckman Coulter, Inc.
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Product benchmarking
7.3.9.4. Strategic initiatives
7.3.10. Siemens Healthineers
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. Product benchmarking
7.3.10.4. Strategic initiatives
7.3.11. Leica Microsystems GmbH
7.3.11.1. Company overview
7.3.11.2. Financial performance
7.3.11.3. Product benchmarking
7.3.11.4. Strategic initiatives
7.3.12. Nikon Corporation
7.3.12.1. Company overview
7.3.12.2. Financial performance
7.3.12.3. Product benchmarking
7.3.12.4. Strategic initiatives
7.3.13. Olympus Corporation
7.3.13.1. Company overview
7.3.13.2. Financial performance
7.3.13.3. Product benchmarking
7.3.13.4. Strategic initiatives
7.3.14. Bio-Rad Laboratories, Inc.
7.3.14.1. Company overview
7.3.14.2. Financial performance
7.3.14.3. Product benchmarking
7.3.14.4. Strategic initiatives
著作権 ©2022 無断複写・転載を禁じます
